MA-HOLOGIC,-INC.
The world faces an emergency in women’s health even as the COVID-19 pandemic wanes, according to one of the largest annual updates on women’s well-being — the Hologic Global Women’s Health Index.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240116169105/en/
Women’s health innovation company Hologic, Inc. (Nasdaq: HOLX) partners with Gallup to create the Index, which in its third year shows that billions of women are not getting tested for potentially life-threatening conditions. The Index also shows that more women are sad, angry and worried now than at the height of the pandemic. Many young women don’t feel safe walking alone in their communities at night, and nearly 1 billion women spend a lot of their day in physical pain.
This year’s Index will be released today at the World Economic Forum in Davos, Switzerland. The launch event was convened by Goals House, a community that comes together at significant global moments throughout the year to drive progress toward the United Nations (UN) Sustainable Development Goals (SDGs).
The Index fills a critical gap in knowledge about the health, safety and well-being of women worldwide. Based on interviews with more than 147,000 women and men in 143 countries and territories, it represents the voices of 97% of the world’s women and girls aged 15 and older.
“The new Index findings make it exceedingly evident that, as countries emerge from the COVID-19 pandemic, women’s health remains in a state of emergency,” said Stephen P. MacMillan, Chairman, President and CEO of Hologic. “It’s time for world leaders to take a bolder stand for women and girls. Investing in women’s health not only benefits individual women, but also their families, communities and economies.”
Key findings from this year’s Index:
-
Testing for major health conditions remains low. Most women didn’t receive key tests in the past 12 months, meaning that billions of women went untested for potentially life-threatening conditions:
- Only 36% were tested for high blood pressure — a major risk factor for heart disease and stroke.
- 19% were tested for diabetes, a leading cause of death for women.
- 11% were tested for any type of cancer.
- 10% were tested for a sexually transmitted disease or infection (STD/STI) — leaving nearly 2 billion women of reproductive age at risk of infertility, increased maternal and fetal mortality, and deadly diseases.
- Emotional health is worsening: More women say they are sad, angry and worried now than three years ago. About 4 in 10 women experienced worry and stress during a lot of the previous day, and women are more likely than men to report feeling these emotions. For example, women are 20% more likely than men to say they experience sadness daily.
-
Other striking findings:
- Physical pain is a significant problem. Nearly 1 billion women worldwide spent a lot of the previous day in physical pain.
- Housing challenges continue. The percentage of women struggling to afford shelter has increased by more than half in the last decade.
- Young women don’t feel safe. Many women, including more than 4 in 10 young women aged 15 to 24, do not feel safe walking alone at night.
Based on survey responses, the Index assigns a women’s health score to each country or territory. Taiwan led the world for the third consecutive year, scoring 72 out of a possible 100. Other top scores went to Kuwait (68), Austria (67) and Germany (67). The lowest scores went to the Democratic Republic of Congo (36), Sierra Leone (34) and Afghanistan (26).
The United States fell seven places from its ranking in the second year of the survey to number 30, on par with Kazakhstan. The United Kingdom and France both scored 60, a few points above the global average.
“The Index serves as a wake-up call that improving women’s health needs to be a top priority. If we follow the roadmap set out in this Index, we can meaningfully improve the health and well-being of women for generations to come,” said MacMillan.
This year’s Index report includes country spotlights, including case studies on what is working well. South Korea is a consistent leader in cancer testing, and after recent prioritization, Costa Rica is among the top countries for blood pressure testing.
To see the full Index and related resources, visit WomensHealthIndex.com.
About Hologic, Inc.
Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. Its advancements include invention of the world’s first commercial 3D mammography system to find breast cancer earlier; leadership in testing for cervical cancer, sexually transmitted infections and respiratory illnesses; and minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding.
About Gallup
Gallup delivers analytics and advice to help leaders and organizations solve their most pressing problems. Combining more than 80 years of experience with its global reach, Gallup knows more about the attitudes and behaviors of employees, customers, students and citizens than any other organization in the world.
SOURCE: Hologic, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240116169105/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DAIICHI-SANKYO31.8.2024 17:01:35 CEST | Press release
Daiichi Sankyo Shines a Light on Inequalities and Unmet Needs in Care as Part of Its Commitment to People With Cardiovascular Disease
SUZANO31.8.2024 00:41:35 CEST | Press release
Suzano completes purchase of 15% stake in Lenzing AG
ANT-INTERNATIONAL30.8.2024 20:47:31 CEST | Press release
Ant International Collaborates with Brazilian Partners to Drive Financial Inclusion with Innovative Credit Tech Solutions
NJ-WIPRO-LIMITED30.8.2024 16:21:28 CEST | Press release
Wipro Appoints Srikumar Rao as Global Head of Its Engineering Edge Business Line
MA-ALNYLAM30.8.2024 12:01:34 CEST | Press release
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom